The importance of S1P for survival and drug resistance has been well documented in hematological malignancies but is more commonly attributed to deregulation of Sphk1 or Ugcg rather than to reduced levels of Sgpp1 [Marfe et al., 2011; Casson et al., 2013]. This evidence concerns the gene SPHK1 and hematologic disorder.